In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

In a video interview, William K. Oh, MD, director of precision medicine at Yale Cancer Center and Smilow Cancer Hospital discusses the latest breakthroughs in advanced prostate cancer treatment.

Dr. Jonathan R. Strosberg, discussed results of the CABINET trial evaluating Cabometyx versus placebo in advanced ...

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

ITM announces positive Phase 3 results for ITM-11 in neuroendocrine tumours, paving the way for a potential new treatment ...

Gigi Moore’s tumor is caused by Zollinger-Ellison Syndrome, a rare cancer mostly found in men over 50. Since her diagnosis, James has been right by her side.

The Endocrine Society and the European Society of Endocrinology (ESE) are delighted to announce Professor Ashley Grossman, F.Med.Sci., as the winner of the 2025 Transatlantic Alliance Award.

Some people use Zollinger-Ellison syndrome and gastrinoma interchangeably. Learn the similarities and differences between the ...

Aaron Rejino and loyal Rejino Barbeque customers mourned the loss of Christina Rejino. The co-owner passed away on Jan. 14 ...

Patients on the firm's SSTR-targeted radiopharmaceutical had improved progression-free survival compared to patients on an mTor inhibitor in a Phase III trial.

ITM's lutetium-containing therapy extended progression-free survival versus everolimus in patients with a specific kind of ...

Lantheus strengthens its radiopharmaceutical business with Evergreen and Life Molecular acquisitions, adding oncology and ...